Cargando…
There is no market for new antibiotics: this allows an open approach to research and development
There is an increasingly urgent need for new antibiotics, yet there is a significant and persistent economic problem when it comes to developing such medicines. The problem stems from the perceived need for a “market” to drive commercial antibiotic development. In this article, we explore abandoning...
Autores principales: | Klug, Dana M., Idiris, Fahima I. M., Blaskovich, Mark A. T., von Delft, Frank, Dowson, Christopher G., Kirchhelle, Claas, Roberts, Adam P., Singer, Andrew C., Todd, Matthew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237369/ https://www.ncbi.nlm.nih.gov/pubmed/34250265 http://dx.doi.org/10.12688/wellcomeopenres.16847.1 |
Ejemplares similares
-
CERN2Market Hackathon
por: Unknown, Unknown
Publicado: (2018) -
Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections
por: Singer, Andrew C., et al.
Publicado: (2019) -
Toxic confusion: the dilemma of antibiotic regulation in West German food production (1951–1990)
por: Kirchhelle, Claas
Publicado: (2016) -
CERN openlab Open Day
por: Purcell, Andrew Robert
Publicado: (2015) -
IdeaSquare Open Doors
por: Marcelloni, Claudia
Publicado: (2023)